ACP solicits member input on CDC survey
ACP is making available to its members a Web survey on the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) project, sponsored by the CDC. The survey focuses on hereditary nonpolyposis colorectal cancer or Lynch syndrome and UGT1A1 testing and is intended to determine physicians' level of awareness and interest in the EGAPP process.
ACP is making available to its members a Web survey on the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) project, sponsored by the CDC. The survey focuses on hereditary nonpolyposis colorectal cancer or Lynch syndrome and UGT1A1 testing and is intended to determine physicians' level of awareness and interest in the EGAPP process.
EGAPP is a nonfederal, multidisciplinary working group whose goal is to establish a systematic, evidence-based process to assess the effectiveness of selected genetic tests that are in transition from research to clinical and public health practice. Participation in the survey is voluntary and is estimated to take 7 to 10 minutes. Responses are anonymous and will not be linked to identity or email address. Click here to participate by March 31, 2010.
Read ACP Internist columnist and genomics expert W. Gregory Feero, MD, PhD, as he discusses EGAPP's impact on internal medicine.